SIBN
SI-BONE, Inc.NASDAQHealthcare$13.12+0.85%ClosedMarket Cap: $579.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.24
P/S
2.90
EV/EBITDA
-64.06
DCF Value
$38.31
FCF Yield
-1.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
79.6%
Operating Margin
-11.1%
Net Margin
-9.4%
ROE
-11.0%
ROA
-7.9%
ROIC
-10.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $56.4M | 79.0% | $-2.5M | $-1.6M | $-0.04 | — |
| FY 2025 | $200.9M | 79.6% | $-22.3M | $-18.9M | $-0.44 | — |
| Q3 2025 | $48.7M | 79.8% | $-5.4M | $-4.6M | $-0.11 | — |
| Q2 2025 | $48.6M | 79.8% | $-7.0M | $-6.2M | $-0.14 | — |
| Q1 2025 | $47.3M | 79.7% | $-7.5M | $-6.5M | $-0.15 | — |
| Q4 2024 | $49.0M | 79.1% | $-5.5M | $-4.5M | $-0.11 | — |
| FY 2024 | $167.2M | 79.0% | $-35.2M | $-30.9M | $-0.75 | — |
| Q3 2024 | $40.3M | 79.1% | $-7.6M | $-6.6M | $-0.16 | — |
| Q2 2024 | $40.0M | 79.0% | $-10.1M | $-8.9M | $-0.22 | — |
| Q1 2024 | $37.9M | 78.9% | $-12.0M | $-10.9M | $-0.27 | — |
| Q4 2023 | $38.9M | 73.8% | $-12.5M | $-11.0M | $-0.27 | — |
| FY 2023 | $138.9M | 78.8% | $-46.9M | $-43.3M | $-1.13 | — |